Patient-Friendly Explanation
A faecal microbiota transplant means putting processed stool from a healthy lean donor into another person’s gut, usually by capsule, tube or enema. Researchers have found that gut bacteria differ between leaner and heavier people, so the transplant is being studied as a way to reset those bacteria. It is still experimental for weight loss and is not a standard treatment.
Clinical Definition
Faecal microbiota transplantation delivers an entire donor microbial community by nasogastric or nasojejunal tube, colonoscopy, enema or oral capsules. Proof-of-concept studies reported improved peripheral insulin sensitivity after lean-donor infusion, but effects on body weight and adiposity are inconsistent and short-lived, limited by host genotype, diet and baseline microbial diversity. FMT is established therapy only for recurrent Clostridioides difficile infection; obesity indications remain investigational, and safety concerns include transmission of multidrug-resistant organisms and of donor metabolic phenotypes.
Why It Matters
Understanding FMT clarifies the gut microbiome’s genuine but modest role in energy harvest and satiety signalling, and counters commercial claims about microbiome reset programmes. For most patients, dietary fibre, fermented foods, behavioural change and approved weight-loss medication remain the evidence-based levers.